Quercetin-induced ubiquitination and down-regulation of Her-2/neu.

Quercetin-induced ubiquitination and down-regulation of Her-2/neu.
复制标题

槲皮素引起的泛素化和HER-2/NEU的下调。

DOI:
10.1002/jcb.21859
复制
发表时间:
2008-10-01
影响因子:
4
通讯作者:
Lee, Yong J.
Lee, Yong J.
中科院分区:
生物学2区
文献类型:
--
作者:
Jeong, Jae-Hoon;An, Jee Young;Kwon, Yong Tae;Li, Lu-Yuan;Lee, Yong J.

文献摘要

参考文献

被引文献

相似文献

Her-2/neu (ErbB2) is a transmembrane tyrosine kinase and acts as a co-receptor for the other EGFR family members. It is well known that high expression of Her-2/neu is associated with a poor prognosis in breast cancer. Quercetin, a flavonoid present in many vegetables and fruits, has been studied extensively as a chemoprevention agent in several cancer models. In this study, we observed that quercetin decreased the level of Her-2/neu protein in time- and dose-dependent manners and also inhibited the downstream survival PI3K-Akt signaling pathway in Her-2/neu-overexpressing breast cancer SK-Br3 cells. We also observed that quercetin induced polyubiquitination of Her-2/neu. When the proteasome pathway was blocked by MG-132 during quercetin treatment, accumulation of the NP-40 insoluble form of Her-2/neu occurred. Interestingly, data from immunocomplex studies revealed that quercetin promoted interaction between Her-2/neu and Hsp90 which is a molecular chaperone involved in stabilization of Her-2/neu. In this condition, inhibition of Hsp90 activity by a specific inhibitor, geldanamycin (GA), or intracellular ATP depletion caused dissociation of Hsp90 from Her-2/neu and promoted ubiquitination and down-regulation of Her-2/neu protein. In addition, the carboxyl terminus of Hsc70-interacting protein (CHIP), a chaperone-dependent E3 ubiquitin ligase, played a crucial role in the quercetin-induced ubiquitination of Her-2/neu. Inhibition of tyrosine kinase activity of Her-2/neu by quercetin could indicate an lateration in the Her-2/neu structure which promotes CHIP recruitments and down-regulation of Her-2/neu. We believe that by using quercetin, new therapeutic strategies can be developed to treat Her-2/neu overexpressing cancers.
DOI: 10.1073/pnas.122249299
发表时间: 2002-06-25
影响因子: 11.1
作者:
Özcelik, C;Erdmann, B;Garratt, AN
通讯作者: Garratt, AN
DOI: 10.1124/mol.107.034041
发表时间: 2007-06-01
影响因子: 3.6
作者:
Jeon, Hyunchu;Kim, Heejung;Jung, Yunjin
通讯作者: Jung, Yunjin
DOI: 10.1016/j.jnutbio.2004.10.010
发表时间: 2005-03-01
影响因子: 5.6
作者:
Kim, WK;Bang, MH;Park, JHY
通讯作者: Park, JHY
DOI: 10.1016/j.bbamcr.2006.11.004
发表时间: 2007-03-01
影响因子: 5.1
作者:
Jung, Yunjin;Xu, Wanping;Neckers, Len
通讯作者: Neckers, Len
DOI: 10.1038/378386a0
发表时间: 1995-11-23
期刊: NATURE
影响因子: 64.8
作者:
MEYER, D;BIRCHMEIER, C
通讯作者: BIRCHMEIER, C